Immunotherapy News from UC San Diego

6/28/2018
Emerging CAR-T immunotherapies leverage modified versions of patient’s T-cells to target and kill cancer cells. In a new study, researchers at University of California San Diego School of Medicine and ...
6/25/2018
Scienmag

​Features Michael Karin, PhD, Andrew Lowy, MD, Jack Bui, MD, PhD, Greg Daniels, MD, PhD, and Dan Kaufman ...

6/11/2018
La Jolla Light

​Authored by Scott Lippman, MD, and features Razelle Kurzrock, MD, Jason Sicklick, MD, Sandip Patel, MD, and Ezra Cohen, ...

4/30/2018
60 Minutes

​Features Kang Zhang, MD, PhD

4/23/2018
Healthline

​Features Sandip Patel, MD

4/9/2018
Nature

​Features Razelle Kurzrock, MD

4/5/2018
Forbes

​Features Ida Deichaite, PhD, Christina Jamieson, PhD, and Pablo Tamayo, PhD

2/13/2018
Tribune-Review

​Features Sandip Patel, MD

1/31/2018
La Jolla Light

​Authored by Scott Lippman, MD, and features Sandip Patel, MD, Jason Sicklick, MD, Razelle Kurzrock, MD, and Ezra Cohen, ...

1/22/2018
Healthline

​Features Moores Cancer Center at UC San Diego Health

1/15/2018
ScienceDaily

​Features Peter Yingxiao Wang, PhD, and Shu Chien, MD, PhD

12/4/2017
San Diego Union Tribune

​Features Dan Kaufman, MD, PhD, and Catriona Jamieson, MD, PhD

11/27/2017
A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Founda ...
11/14/2017
Health IT News

​Features Razelle Kurzrock, MD

11/8/2017
Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that’s because inflammation directly affects cancer cells, stimulating their division and pr ...
10/24/2017
Times of San Diego

​Features Ezra Cohen, MD

10/23/2017
La Jolla Light

​Authored by Scott Lippman, MD, and features Ezra Cohen, MD

10/17/2017
Associated Press

​Features Razelle Kurzrock, MD, and Shumei Kato, MD

10/16/2017
San Diego Union Tribune

​Features Razelle Kurzrock, MD, and Shumei Kato, MD

10/9/2017
La Prensa

​Features Razelle Kurzrock, MD

10/1/2017
In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhib ...
9/21/2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego Sch ...
8/28/2017
In mouse experiments, researchers at University of California San Diego School of Medicine have discovered that drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor ...
7/20/2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School o ...
4/19/2017
Rock star drummer Rikki Rockett feels very lucky to be on tour with his band, Poison. A year ago, he didn’t know if he would survive tongue cancer but after participating in an immunotherapy clinical ...
1/20/2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medic ...
12/1/2016
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role ...
9/19/2016
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers id ...
9/16/2016
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, wri ...
9/7/2016
When 28 distinguished individuals convened earlier this year to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiati ...
9/6/2016
Rikki Rockett, drummer in the band Poison, shares his story of oral cancer, chemotherapy and immunotherapy. Learn how this rock star went from almost losing his tongue to now being able to see his chi ...
8/4/2016
Robert Legaspi was 9 years old when he was first diagnosed with acute lymphoblastic leukemia (ALL). This year, at age 27, his leukemia returned for the fourth time. This time was different, though — o ...
7/18/2016
Rikki Rockett, drummer for the band Poison, got the best news of his life last week: his cancer is gone. Rockett was diagnosed with oral cancer more than a year ago. Several months ago, he came to Moo ...
6/30/2016
Using a database of human tumor genomic data, researchers at the University of California San Diego, School of Medicine and Moores Cancer Center discovered that mutation hotspots known as kataegis are ...
2/23/2016
Cancer immunology is based upon boosting the body’s own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Ce ...
4/29/2015
Researchers at the University of California, San Diego School of Medicine report that blocking or removing immune-suppressing cells allows a special type of chemotherapy — and the immune cells it acti ...